Esperion Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Esperion Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2013 to Q1 2024.
  • Esperion Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Esperion Therapeutics, Inc. annual Depreciation for 2023 was $164K, a 67.2% decline from 2022.
  • Esperion Therapeutics, Inc. annual Depreciation for 2022 was $500K, a 18.3% decline from 2021.
  • Esperion Therapeutics, Inc. annual Depreciation for 2021 was $612K, a 11.9% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 -$81K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $81K -$72K -47.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $153K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $153K +$47K +44.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q1 2020 $106K +$35K +49.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $71K +$10K +16.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 $61K -$8K -11.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $69K +$5K +7.81% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q1 2016 $64K +$5K +8.48% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q1 2015 $59K +$47K +392% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q1 2014 $12K -$20K -62.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $32K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.